🔬 Science
12h ago
Gene clues reveal why some rare leukemia patients resist tagraxofusp therapy
Source ↗
👁 0
💬 0
Researchers at The University of Texas MD Anderson Cancer Center have identified why some patients with a rare type of leukemia, called blastic plasmacytoid dendritic cell neoplasm (BPDCN), eventually develop resistance to tagraxofusp, the first Food and Drug Administration-approved treatment for this disease.
Comments (0)